Most Read

AstraZeneca, along with its biologics research and development arm MedImmune, has secured approval from the Japanese ministry of health, labour and welfare for Imfinzi (durvalumab) as maintenance therapy

CVC Fund VII has agreed to acquire holding company, FIMEI, which owns a 51% stake in Recordati. The consortium is comprised of PSP Investments and StepStone. FIMEI chairman and

According to the American Heart Association, more than 900,000 people are diagnosed with heart failure every year in the United States. The condition, which results from the failure

This collaboration broadens AbbVie’s oncology research to access advanced precision medicine technology to expand the development of potentially life-changing treatments for patients with cancer. Chimeric Antigen Receptor T-cell